Cytokinetics, IncorporatedCYTKNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+122.2%
5Y CAGR+28.4%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+122.2%/yr
vs -29.1%/yr prior
5Y CAGR
+28.4%/yr
Recent acceleration
Acceleration
+151.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.5x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 376.56% |
| 2024 | 145.34% |
| 2023 | -92.04% |
| 2022 | 34.30% |
| 2021 | 26.15% |
| 2020 | 107.79% |
| 2019 | -14.71% |
| 2018 | 135.64% |
| 2017 | -87.44% |
| 2016 | 271.30% |